EP1997826A3 - Synthetic ligands for immunoglobulins and pharmaceutical compositions containing them - Google Patents
Synthetic ligands for immunoglobulins and pharmaceutical compositions containing them Download PDFInfo
- Publication number
- EP1997826A3 EP1997826A3 EP08009793A EP08009793A EP1997826A3 EP 1997826 A3 EP1997826 A3 EP 1997826A3 EP 08009793 A EP08009793 A EP 08009793A EP 08009793 A EP08009793 A EP 08009793A EP 1997826 A3 EP1997826 A3 EP 1997826A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- immunoglobulins
- pharmaceutical compositions
- compositions containing
- synthetic ligands
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
X1-Arg-Thr-Tyr- (S)
where:
X1 is the residue of an amino acid, of an amino acid derivative, of a carboxylic acid, or of some other derivative capable of binding covalently to the amino group of arginine, comprising at least one aromatic group.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI20071119 ITMI20071119A1 (en) | 2007-06-01 | 2007-06-01 | NEW SYNTHETIC LIGANDS FOR IMMUNOGLOBULINES AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1997826A2 EP1997826A2 (en) | 2008-12-03 |
EP1997826A3 true EP1997826A3 (en) | 2009-07-29 |
Family
ID=38537513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08009793A Withdrawn EP1997826A3 (en) | 2007-06-01 | 2008-05-29 | Synthetic ligands for immunoglobulins and pharmaceutical compositions containing them |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1997826A3 (en) |
IT (1) | ITMI20071119A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102016961B1 (en) * | 2011-02-09 | 2019-09-02 | 노보자임스 에이/에스 | Peptide for use in the treatment of skin conditions |
JP5982676B2 (en) * | 2011-02-28 | 2016-08-31 | 学校法人 いわき明星大学 | Biotinylated peptide compound having anti-PAF activity |
GB2513405A (en) | 2013-04-26 | 2014-10-29 | Adc Biotechnology Ltd | Method of synthesising ADCs using affinity resins |
GB201419185D0 (en) | 2014-10-28 | 2014-12-10 | Adc Biotechnology Ltd | Method of synthesising ADCs using affinity resin |
GB201419184D0 (en) | 2014-10-28 | 2014-12-10 | Adc Biotechnology Ltd | Method of synthesising biomolecule-effector/reporter-conjugates using affinity resins |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0752425A2 (en) * | 1995-06-21 | 1997-01-08 | TECNOGEN Società Consortile per azioni | Peptide ligands for the constant region of immunoglobulins |
WO1998005347A1 (en) * | 1996-07-22 | 1998-02-12 | The Trustees Of Columbia University In The City Of New York | Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
WO1998026794A1 (en) * | 1996-12-16 | 1998-06-25 | Tecnogen S.C.P.A. | Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
US20010045384A1 (en) * | 2000-04-28 | 2001-11-29 | Bozidar Stipanovic | Simulated activity of protein a displayed by ligands attached to a cellulose bead surface |
WO2002061087A2 (en) * | 2000-12-19 | 2002-08-08 | Lifespan Biosciences, Inc. | Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides |
US20030143158A1 (en) * | 2000-12-23 | 2003-07-31 | Wescott Charles R. | Fibrin binding moieties useful as imaging agents |
WO2005001480A1 (en) * | 2003-06-27 | 2005-01-06 | Proteome Systems Intellectual Property Pty Ltd | Method of isolating a protein |
US20060073563A1 (en) * | 2004-09-02 | 2006-04-06 | Xencor, Inc. | Erythropoietin derivatives with altered immunogenicity |
-
2007
- 2007-06-01 IT ITMI20071119 patent/ITMI20071119A1/en unknown
-
2008
- 2008-05-29 EP EP08009793A patent/EP1997826A3/en not_active Withdrawn
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0752425A2 (en) * | 1995-06-21 | 1997-01-08 | TECNOGEN Società Consortile per azioni | Peptide ligands for the constant region of immunoglobulins |
WO1998005347A1 (en) * | 1996-07-22 | 1998-02-12 | The Trustees Of Columbia University In The City Of New York | Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
WO1998026794A1 (en) * | 1996-12-16 | 1998-06-25 | Tecnogen S.C.P.A. | Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
US20010045384A1 (en) * | 2000-04-28 | 2001-11-29 | Bozidar Stipanovic | Simulated activity of protein a displayed by ligands attached to a cellulose bead surface |
WO2002061087A2 (en) * | 2000-12-19 | 2002-08-08 | Lifespan Biosciences, Inc. | Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides |
US20030143158A1 (en) * | 2000-12-23 | 2003-07-31 | Wescott Charles R. | Fibrin binding moieties useful as imaging agents |
WO2005001480A1 (en) * | 2003-06-27 | 2005-01-06 | Proteome Systems Intellectual Property Pty Ltd | Method of isolating a protein |
US20060073563A1 (en) * | 2004-09-02 | 2006-04-06 | Xencor, Inc. | Erythropoietin derivatives with altered immunogenicity |
Non-Patent Citations (1)
Title |
---|
VERDOLIVA A ET AL: "Affinity purification of polyclonal antibodies using a new all-D synthetic peptide ligand: comparison with protein A and protein G", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER, AMSTERDAM, NL, vol. 271, no. 1-2, 20 December 2002 (2002-12-20), pages 77 - 88, XP004393927, ISSN: 0022-1759 * |
Also Published As
Publication number | Publication date |
---|---|
EP1997826A2 (en) | 2008-12-03 |
ITMI20071119A1 (en) | 2008-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2390265A3 (en) | Insulinotropic peptide derivative wherein its N-terminal amino acid is modified | |
EP2341142A3 (en) | HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising same | |
EP2407475A3 (en) | Synthetic Bile Acid Composition, Method, and Preparation | |
WO2009004315A8 (en) | Isolated peptides and uses thereof | |
WO2009009727A3 (en) | Ghrh analogs and therapeutic uses thereof | |
MY148483A (en) | 4,5-diphenyl-pyrimidinyl-oxy or-mercapto substituted carboxylic acids, method for the production and use thereof as medicaments | |
MX2008009493A (en) | Novel peptide and use thereof. | |
HK1105982A1 (en) | Antimicrobial peptides comprising an arginine-and/or lysine-containing motif | |
EP1626055A3 (en) | Non-mammalian GnRH analogs and uses thereof in the regulation of the immune system | |
WO2007062610A3 (en) | Four branched dendrimer-peg for conjugation to proteins and peptides | |
WO2008118017A3 (en) | Prame derived peptides and immunogenic compositions comprising these | |
EP1997826A3 (en) | Synthetic ligands for immunoglobulins and pharmaceutical compositions containing them | |
EP2251348A3 (en) | Peptides and their use | |
EP2628749A3 (en) | Antimicrobial kinocidin compostions and methods of use | |
WO2005080338A8 (en) | New pharmaceutical compositions based on benzilic acid esters and soluble tnf receptor fusion proteins | |
EP2039367A4 (en) | Prophylactic/therapeutic agent for neurodegenerative disease | |
WO2007115175A3 (en) | Cyclic natriuretic peptide constructs | |
MXPA05002991A (en) | Ghrh analogues. | |
WO2009080764A3 (en) | Oral or nasal administration of compounds comprising amino acid sequences | |
WO2007145589A8 (en) | Peptides that are capable of binding to amyloid-beta peptide. | |
WO2008135661A3 (en) | Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation | |
WO2011093932A3 (en) | Design of fibrinogen and fibrinogen derived products with reduced bacterial binding by using modified sequences of fibrinogen chains | |
MX2011012742A (en) | Methylglyoxal-scavenging compounds and their use for the prevention and treatment of pain and/or hyperalgesia. | |
WO2007139833A3 (en) | Imidazoazephinone compounds | |
WO2009148252A3 (en) | Stroke-targeting peptide and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
AKX | Designation fees paid | ||
REG | Reference to a national code |
Ref country code: DE Ref legal event code: 8566 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100130 |